Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

Always good to start somewhere. I’d remove vigabatrin altogether and cut markets for Vyvanse and OxyContin in half as they shift from brand to generic with competitors. To offset this, I’d also model a more generous market capture. Let’s see that Vyvanse or OxyContin approval first